Market Place
Sourcing Support
Drugmaker Mundipharma`s China unit sale fails to find buyer, sources say
28 Aug 2024 //
REUTERS
Cidara Therapeutics Reports Q2 2024 Results And Corporate Update
13 Aug 2024 //
GLOBENEWSWIRE
MAbxience Names New Chief Executive Officer
10 May 2024 //
CONTRACT PHARMA
Mundipharma Acquires Rezafungin, Reinforces Infectious Disease Commitment
24 Apr 2024 //
BUSINESSWIRE
Mundipharma, Vectura To Reformulate Flutiform® For Lower Emissions
16 Apr 2024 //
BUSINESSWIRE
Mundipharma announces European approval of REZZAYO
22 Dec 2023 //
BUSINESSWIRE
Mundipharma, Mundipharma Medical , and Acrotech Biopharma Enter into Agreement
01 Aug 2023 //
PR NEWSWIRE
EMA Accepts Rezafungin MAA for the Treatment of Invasive Candidiasis
22 Aug 2022 //
BUSINESSWIRE
Mundipharma and Cidara report positive PIII results into candidemia treatment
26 Apr 2022 //
PHARMAFILE
Mundipharma and Cidara Therapeutics Announce First Presentation of Results
25 Apr 2022 //
BUSINESSWIRE
Cidara, Mundipharma to Present Results from Global Phase 3 Trial of Rezafungin
14 Apr 2022 //
GLOBENEWSWIRE
Cidara, Mundipharma Show +ve Topline Results from Phase 3 Trial of Rezafungin
14 Dec 2021 //
BUSINESSWIRE
Cidara and Mundipharma Announce Completion of Phase 3 Trial of Rezafungin
17 Aug 2021 //
GLOBENEWSWIRE
Boyu, Sinopharm among bidders shortlisted for Mundipharma China -sources
08 Jun 2021 //
REUTERS
Mundipharma seeks bids for China unit in over $1 billion deal -sources
05 May 2021 //
REUTERS
Invasive candidiasis treatment rezafungin wins orphan drug status
28 Jan 2021 //
PHARMATIMES
Mundipharma and Cidara’s rezafungin gets Orphan Drug Designation in EU
27 Jan 2021 //
PHARMACEUTICAL-TECHNOLOGY
Julie Dehaene-Puype and Erik Nordkamp appointed as new Commercial Officers
19 Jan 2021 //
BUSINESSWIRE
Mundipharma Welcomes the New 2020 Clinical Practice Guideline from KDIGO
01 Oct 2020 //
BUSINESSWIRE
Orphan Drug Designation granted to tinostamustine in EU for very rare form
04 Aug 2020 //
PHARMAFIELD
Laboratory Studies Confirm BETADINE(R) Antiseptic Products` Effectiveness COVID
08 Jul 2020 //
PRNEWSWIRE
Malaysia explores effectiveness of Betadine against coronavirus
02 Jul 2020 //
BIOSPECTRUMASIA
Marc Princen appointed new Global CEO for Mundipharma
14 Jun 2020 //
BUSINESSWIRE
Mundipharma, Biosolution to market CartiLife in South Korea
08 Jan 2020 //
BIOSPECTRUM ASIA
Mundipharma, Biosolution to market CartiLife in South Korea
07 Jan 2020 //
BIOSPECTRUM ASIA
Mundipharma, Biosolution to market CartiLife in South Korea
07 Jan 2020 //
BIOSPECTRUM ASIA
Hana Pharm submits NDA for anesthetic agent
31 Dec 2019 //
BIOSPECTRUMASIA
Facing scrutiny in the US, Purdue Pharma markets OxyContin overseas
21 Dec 2019 //
WSWS
Mundipharma`s Pegfilgrastim Receives Approval In Europe
19 Dec 2019 //
EMA
Mundipharma demonstrates superiority of non-opioid Penthrox in relieving pain
16 Oct 2019 //
PHARMACEUTICAL TECHNOLOGY
Chaotic talks show challenge of reaching opioid settlemen
13 Sep 2019 //
APNEWS
Purdue Reaches Tentative $12 Billion Settlement, But Some Opposition Remains
12 Sep 2019 //
BIOSPACE
Mundipharma bets $568m on antifungal treatment
10 Sep 2019 //
INPHARMATECHNOLOGIST
Mundipharma, Cidara ink $568M deal for antifungal treatment
05 Sep 2019 //
BIOSPECRUM ASIA
Cidara Therapeutics and Mundipharma Form Strategic Partnership to Develop and Commercialize Rezafungin
04 Sep 2019 //
BUSINESSWIRE
Beset by lawsuits and criticism in U.S., opioid makers eye new market in India
31 Aug 2019 //
FIERCE PHARMA
Mundipharma Announces the Licence Extension Sub for Invokana® Vokanamet®
21 Aug 2019 //
BUSINESSWIRE
Mundipharma gains rights to Novartis eye drugs in Taiwan
25 Jul 2019 //
THE PHARMALETTER
Mundipharma Acquires Rights to Orexo`s Zubsolv
10 Jul 2019 //
CONTRACT PHARMA
Purdue hires Ducharme as CSO to aid expansion beyond opioids
03 Jul 2019 //
FIERCE BIOTECH
Mundipharma picks up rights to Herceptin biosimilar Tuznue
02 Jul 2019 //
PHARMATIMES
Egis Pharmaceuticals to launch Mundipharma’s Pelmeg in CEE markets
14 Jun 2019 //
PHARMACEUTICAL-TECHNOLOGY
Mundipharma, Grünenthal accused of kickbacks in Italy
30 May 2019 //
PHARMAPHORUM
Purdue money swayed WHO`s opioid prescribing guidelines: report
24 May 2019 //
FIERCE PHARMA
Ex-GSK, Novartis exec named as Mundipharma`s Head of Access
14 May 2019 //
PHARMAFILE
Data show J&J’s Invokana may slow or prevent CKD in diabetes patients
16 Apr 2019 //
PHARMA TIMES
Mundipharma EDO: US FDA grants Orphan Drug Designation for etoposide toniribate
22 Feb 2019 //
BUSINESSWIRE
Mundipharma to distribute Norspan in Japan
10 Dec 2018 //
BIOSPECTRUM
Mundipharma`s Neulasta biosimilar approved in EU
01 Dec 2018 //
PHARMA FILE
Mundipharma name GSK veteran as new Senior Vice President & CFO
01 Dec 2018 //
PHARMA FILE
Mundipharma, Novartis to distribute pain medicine in SE Asia
12 Sep 2018 //
BIOSPECTRUM
Janssen Receives +ve CHMP Opinion to Expand INVOKANA® and VOKANAMET® Labelling
02 Aug 2018 //
BUSINESSWIRE
Neovii, Mundipharma Enter Agreement
05 Jul 2018 //
CONTRACT PHARMA
Mundipharma extends partnership with Kolon Life Science
26 Jun 2018 //
BIOSPECTRUM
Mundipharma inks deal with Korean firm Genewel
07 Jun 2018 //
BIOSPECTRUM
Mundipharma to launch web-based chat bot for feminine care
24 May 2018 //
BIOSPECTRUM
Mundipharma & Endoceutics to Exclusively License Intrarosa™ in MEA Region
21 May 2018 //
PR NEWSWIRE
Herceptin biosimilar Herzuma launched in Europe
04 May 2018 //
PHARMA TIMES
